2024年3月8日,Nat Rev Drug Discov发表文章Top companies and drugs by sales in 2023,介绍了2023年销售额最高的公司和药品。 以往年度的回顾文章参见 Nat Rev Drug Discov|2022年销售额排名Top10的制药公司和药品 Nat Rev Drug Discov|2021年制药公司和药物的销售额Top10 正如人们所预料的那样,2023年...
2024年3月8日,Nat Rev Drug Discov发表文章Top companies and drugs by sales in 2023,介绍了2023年销售额最高的公司和药品。 正如人们所预料的那样,2023年制药行业的排名榜发生了变化。辉瑞因其COVID-19疫苗Comirnaty的巨大销售额而连续多年稳居榜首,但后来却一落千丈,由强生取而代之(图1a)。这一新的市...
2024年3月8日,Nat Rev Drug Discov发表文章Top companies and drugs by sales in 2023,介绍了2023年销售额最高的公司和药品。正如人们所预料的那样,2023年制药行业的排名榜发生了变化。辉瑞因其COVID-19疫苗Comirnaty的巨大销售额而连续多年稳居榜首,但后来却一落千丈,由强生取而代之(图1a)。这一新的市场领导...
Over the past few years, the tussle for biopharma's biggest company by sales has largely been contested by Novartis and Pfizer; but a winning streak of blockbuster launches, including the multiple sclerosis drug Ocrevus (ocrelizumab) and PD-L1 inhibitor Tecentriq (atezolizumab) have helped the ...
正在加载 Top drugs and companies by sales in 2018. Nat. Rev. Drug. Disc. Pub Date : 2019-03-12DOI : 10.1038/d41573-019-00049-0 Lisa Urquhart Discover the world’s best science and medicine | Nature.com 查看原文 中文翻译 2018年按销售额划分的顶级药品和公司。 发现世界上最好的科学和...
Companies Research and development Miscellaneous The most important statistics U.S. total medicine spending 2002-2023 Leading therapy areas by pharma revenue in the U.S. 2023 Top pharma products by prescriptions U.S. 2022 U.S. top prescribed drugs based on sales 2023 ...
Pfizer held nine percent of the world's pharmaceutical drug market in 2022. The global market for prescribed medicines is expected to be led by U.S. companies, accompanied by Swiss pharma giants Roche and Novartis. Prescription and over-the-counter drugsThe total global prescription drug market ...
From their conception 125 years ago, Roche has become one of the largest pharmaceutical companies in the world. Having evolved into a global leader in the industry, they specialise in diagnostics and pharmaceuticals, with dominance in cancer treatments due to their popular drugs, Rituxan, Herceptin...
The pharmaceutical industry continues to generate stellar growth and was estimated to be worth an impressive US$1.6 trillion in 2023 with top 10 pharma companies contributing US$491.84 billion, nearly a third of all revenues. In this blog, we reveal the
Gilead has arguably had the best year out of all the pharmaceutical companies on the list, with an incredible increase in profits of nearly 5,000 percent. Gilead Sciences’ portfolio includes antiviral drugs for HIV/AIDS, hepatitis B, hepatitis C, influenza and Covid-19. Among them feat...